Logs: Bennett Institute
The following is a list of all job requests run via OpenSAFELY by Bennett Institute users.
| Status | Project | Workspace | Request ID | Backend | Jobs | User | Started | View request |
|---|---|---|---|---|---|---|---|---|
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 23014 | TPP | 1/1 | Qing Wen | 2 years, 1 month ago 15 May 2024 20:27:09 UTC | View, Job request 23014 |
| Succeeded | OpenSAFELY Internal | therapeutics-risk-groups | 23011 | TPP | 4/4 | Becky Smith | 2 years, 1 month ago 15 May 2024 20:24:41 UTC | View, Job request 23011 |
| Failed | Long COVID-19 Sick Notes | long-covid-sick-notes | 23002 | TPP | 30/92 | Rose Higgins | 2 years, 1 month ago 13 May 2024 16:27:12 UTC | View, Job request 23002 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 22993 | TPP | 2/2 | Qing Wen | 2 years, 1 month ago 10 May 2024 17:01:09 UTC | View, Job request 22993 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-report | 22989 | TPP | 11/11 | Rose Higgins | 2 years, 2 months ago 09 May 2024 17:08:53 UTC | View, Job request 22989 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 22985 | TPP | 1/1 | Qing Wen | 2 years, 2 months ago 09 May 2024 11:27:38 UTC | View, Job request 22985 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 22983 | TPP | 1/1 | Qing Wen | 2 years, 2 months ago 09 May 2024 09:20:48 UTC | View, Job request 22983 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 22981 | TPP | 1/1 | Qing Wen | 2 years, 2 months ago 09 May 2024 08:45:38 UTC | View, Job request 22981 |
| Succeeded | Ethnicity Short Data Report | ethnicity-short-data-report-notebook | 22978 | TPP | 1/1 | Colm Andrews | 2 years, 2 months ago 08 May 2024 17:23:30 UTC | View, Job request 22978 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 22976 | TPP | 1/1 | Qing Wen | 2 years, 2 months ago 08 May 2024 14:25:42 UTC | View, Job request 22976 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 22975 | TPP | 1/1 | Qing Wen | 2 years, 2 months ago 08 May 2024 14:03:18 UTC | View, Job request 22975 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 22970 | TPP | 2/2 | Qing Wen | 2 years, 2 months ago 07 May 2024 16:59:53 UTC | View, Job request 22970 |
| Succeeded | OpenSAFELY Internal | tpp-database-schema | 22966 | TPP | 3/3 | Dave Evans | 2 years, 2 months ago 07 May 2024 10:49:30 UTC | View, Job request 22966 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 22955 | TPP | 2/2 | Qing Wen | 2 years, 2 months ago 04 May 2024 08:58:36 UTC | View, Job request 22955 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 22951 | TPP | 1/1 | Qing Wen | 2 years, 2 months ago 03 May 2024 21:10:39 UTC | View, Job request 22951 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 22950 | TPP | 1/1 | Qing Wen | 2 years, 2 months ago 03 May 2024 20:56:42 UTC | View, Job request 22950 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 22942 | TPP | 2/2 | Qing Wen | 2 years, 2 months ago 03 May 2024 12:02:35 UTC | View, Job request 22942 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 22929 | TPP | 1/1 | Qing Wen | 2 years, 2 months ago 02 May 2024 12:20:15 UTC | View, Job request 22929 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 22928 | TPP | 1/1 | Qing Wen | 2 years, 2 months ago 02 May 2024 11:50:52 UTC | View, Job request 22928 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 22923 | TPP | 1/1 | Qing Wen | 2 years, 2 months ago 02 May 2024 08:41:35 UTC | View, Job request 22923 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 22906 | TPP | 1/1 | Qing Wen | 2 years, 2 months ago 01 May 2024 13:38:31 UTC | View, Job request 22906 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 22903 | TPP | 0/1 | Qing Wen | 2 years, 2 months ago 01 May 2024 12:02:28 UTC | View, Job request 22903 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 22902 | TPP | 0/1 | Qing Wen | 2 years, 2 months ago 01 May 2024 11:52:38 UTC | View, Job request 22902 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 22900 | TPP | 0/1 | Qing Wen | 2 years, 2 months ago 01 May 2024 10:57:02 UTC | View, Job request 22900 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 22898 | TPP | 0/1 | Qing Wen | 2 years, 2 months ago 01 May 2024 10:20:38 UTC | View, Job request 22898 |